Neuphoria Therapeutics
NEUP----
Q4 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Neuphoria Therapeutics(NEUP) the Revenue is 1.143 M (+8710%), Beat estimate;the EPS is -0.95 (+82.88%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B8709.93%
0.00B100.00%
+0.00B8,609.93%
EBIT
TBA--
-0.01B33.65%
----
EPSMiss expectations
-0.9582.88%
-0.5689.91%
-0.39007.03%
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly